Many recurring patients choose walk-in visits because they are quick and easy to fit into a weekly routine, with no long appointment wait times
Challenges and Future Directions of GLP-1 'Central Program' Intervention Current challenge: Individual differences and long-term safety Although GLP-1 injections have shown excellent efficacy in clinical trials, their "central plan" interventions still face challenges: Individual metabolic differences There are significant differences in the response of different patients to GLP-1RA, which are related to factors such as gene polymorphism, gut microbiota composition, and metabolic flexibility
Using a new needle for each injection helps maintain needle sharpness, reduce discomfort, minimize the risk of infection, and ensure accurate insulin delivery
Always consult a qualified medical professional for personalized recommendations.
Previously, Pfizer designed the drug as a twice-daily pill but it faced discontinuation rates of over 50%, possibly due to side effects
EC 3.3.1.1)
